Race-Based Drug Dosing Puts Patients at Risk, Experts Warn

AI Insight

This article examines the problematic practice of using race as a biological variable when determining medication dosages and medical treatments. The authors argue that race is a social construct rather than a biological category, and that dosing medications based on race can lead to inaccurate treatment and perpetuate health disparities. The piece highlights how genetic variation within racial groups often exceeds variation between groups, making race-based prescribing scientifically imprecise and potentially harmful.

Why it matters

Race-based dosing practices in medicine can result in suboptimal patient care and reinforce unfounded biological notions of race. Moving toward more individualized approaches based on actual genetic, environmental, and physiological factors could improve treatment outcomes and promote health equity across diverse patient populations.